首页> 外文OA文献 >Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial
【2h】

Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial

机译:胃癌的D 1和D 2切除术后患者生存:MRC随机手术试验的长期结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Controversy still exists on the optimal surgical resection for potentially curable gastric cancer. Much better long-term survival has been reported in retrospective/non-randomized studies with D 2 resections that involve a radical extended regional lymphadenectomy than with the standard D 1 resections. In this paper we report the long-term survival of patients entered into a randomized study, with follow-up to death or 3 years in 96% of patients and a median follow-up of 6.5 years. In this prospective trial D 1 resection (removal of regional perigastric nodes) was compared with D 2 resection (extended lymphadenectomy to include level 1 and 2 regional nodes). Central randomization followed a staging laparotomy.
机译:关于可治愈的胃癌的最佳手术切除仍存在争议。回顾性/非随机性研究报道,采用D 2切除术与根治性D 1切除术相比,根治性扩大区域淋巴结清扫术的长期生存率要好得多。在本文中,我们报告了进入一项随机研究的患者的长期存活率,对96%的患者进行了3年的死亡随访或6.5年的中位随访。在这项前瞻性试验中,将D 1切除术(切除区域性胃周淋巴结)与D 2切除术(扩大淋巴结切除术以包括1级和2级区域淋巴结切除术)进行了比较。分期剖腹手术后进行中央随机分组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号